Ani Pharmaceuticals (ANIP) Exchange Rate Effect (2024 - 2026)
Ani Pharmaceuticals (ANIP) reported Exchange Rate Effect of $156000.0 for Q1 2026, up 152.53% on a YoY basis from $61776.0 in Q1 2025, and up 111.53% sequentially from -$1.4 million in Q4 2025.
Ani Pharmaceuticals (ANIP) Exchange Rate Effect (2024 - 2026) Analysis & Trends
Ani Pharmaceuticals (ANIP) has 3 years of Exchange Rate Effect data on file, last reported at $156000.0 in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect rose 152.53% year-over-year to $156000.0; the trailing twelve-month figure through Mar 2026 stood at $220000.0 (up 128.68% YoY), and the FY2025 full-year result was -$233000.0, up 50.43% from the prior year.
- Exchange Rate Effect climbed to $156000.0 in Q1 2026, from -$1.4 million in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $841000.0 in Q2 2025 to a low of -$1.4 million in Q4 2025.
- A 3-year average of -$78142.9 and a median of -$75000.0 in 2024 frame the typical range for Exchange Rate Effect.
- Peak annual rise in Exchange Rate Effect reached 868.0% in 2025, while the deepest fall reached 242.53% in 2025.
- Tracing ANIP's Exchange Rate Effect over 3 years: stood at -$395000.0 in 2024, then sank by 242.53% to -$1.4 million in 2025, then jumped by 111.53% to $156000.0 in 2026.
- Business Quant data shows ANIP's Exchange Rate Effect at $156000.0 in Q1 2026, -$1.4 million in Q4 2025, and $576000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -17.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 17.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 7.01 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -4.20 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -5.00 Mn |
| 10 | Ani Pharmaceuticals | 1.64 Bn | 1.33 Bn | 143.88 Mn | 156,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 156,000.00 |
| Mar 31, 2026 | 156,000.00 |
| Dec 31, 2025 | -1.35 Mn |
| Dec 31, 2025 | -1.35 Mn |
| Sep 30, 2025 | 576,000.00 |
| Sep 30, 2025 | 576,000.00 |
| Jun 30, 2025 | 841,000.00 |
| Jun 30, 2025 | 841,000.00 |
| Mar 31, 2025 | -297,000.00 |
| Mar 31, 2025 | -297,000.00 |
| Dec 31, 2024 | -395,000.00 |
| Dec 31, 2024 | -395,000.00 |
| Sep 30, 2024 | -75,000.00 |
| Sep 30, 2024 | -75,000.00 |